Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

REP. SYNAR (D-OKLA.) IN TIGHT PRIMARY RACE: RUNOFF SCHEDULED

Executive Summary

REP. SYNAR (D-OKLA.) IN TIGHT PRIMARY RACE: RUNOFF SCHEDULED for Sept. 15 following inconclusive results in Oklahoma's Aug. 25 congressional primary. Synar, a seven-term representative from Oklahoma's second district, won the largest number of votes with 43% of votes cast in the Democratic primary, but the margin was too narrow to clinch a victory over leading competitor Drew Edmondson. A former district attorney for Muskogee County, Edmondson won 38% of the vote; two other candidates split the remaining votes. A member of the powerful House Energy & Commerce Committee, Synar has been an active participant in the Medicaid rebate debates. Synar drafted but never introduced legislation to replace the current "best price" formula for prices to Medicaid with fixed percentage rebates ("The Pink Sheet" May 25, T&G-3). While Synar moved away from drafting his own plan, he has continued to advocate the need for pricing reforms to industry groups and has indicated that he may support fixed percentage rebate legislation if other sponsors introduce it. Rep. Waxman (D-Calif.) has floated proposals in Congress to modify the Medicaid outpatient rebate program by switching to a fixed percentage rebate of 18.5% in FY 1996, increasing to 19% in 1997 ("The Pink Sheet" Aug. 17, p. 3) and other proposals before the Congress also have raised the notion of fixed rebates ("The Pink Sheet" Aug. 24, p. 3). As a member of the Judiciary subcommittee on intellectual property rights, Synar also sponsored the House patent extension bill for U.S. Bioscience's Ethyol ("The Pink Sheet" July 15, 1991, T&G-1). An Ethyol patent extension of three years was passed by the Senate Judiciary Committee on Aug. 12 ("The Pink Sheet" Aug. 17, p. 10). A House patent extension bill passed Aug. 4 does not include an extension for Ethyol. The issue must be referred to the full Senate. Also through the Judiciary Committee, Synar was involved in crafting product liability legislation in the late 1980s. Synar's reelection campaign apparently is encountering serious opposition from several large interest groups, including the tobacco, oil and banking industries, as well as the National Rifle Association and the cattlemen. Simply by virtue of his longevity, Synar also may be suffering from the wave of anti-incumbent sentiment affecting elections throughout the country.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS021410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel